Cargando…
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883068/ https://www.ncbi.nlm.nih.gov/pubmed/36716924 http://dx.doi.org/10.1016/j.jid.2022.12.023 |
| _version_ | 1784879425800634368 |
|---|---|
| author | Fenizia, Claudio Moltrasio, Chiara Ottobrini, Luisa Utyro, Olga Genovese, Giovanni Vanetti, Claudia Trabattoni, Daria Marzano, Angelo V. |
| author_facet | Fenizia, Claudio Moltrasio, Chiara Ottobrini, Luisa Utyro, Olga Genovese, Giovanni Vanetti, Claudia Trabattoni, Daria Marzano, Angelo V. |
| author_sort | Fenizia, Claudio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9883068 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98830682023-01-30 SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris Fenizia, Claudio Moltrasio, Chiara Ottobrini, Luisa Utyro, Olga Genovese, Giovanni Vanetti, Claudia Trabattoni, Daria Marzano, Angelo V. J Invest Dermatol Letters to the Editor The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology. 2023-01-28 /pmc/articles/PMC9883068/ /pubmed/36716924 http://dx.doi.org/10.1016/j.jid.2022.12.023 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letters to the Editor Fenizia, Claudio Moltrasio, Chiara Ottobrini, Luisa Utyro, Olga Genovese, Giovanni Vanetti, Claudia Trabattoni, Daria Marzano, Angelo V. SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris |
| title | SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris |
| title_full | SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris |
| title_fullStr | SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris |
| title_full_unstemmed | SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris |
| title_short | SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris |
| title_sort | sars-cov-2 vaccination effectiveness in rituximab-treated patients affected by pemphigus vulgaris |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883068/ https://www.ncbi.nlm.nih.gov/pubmed/36716924 http://dx.doi.org/10.1016/j.jid.2022.12.023 |
| work_keys_str_mv | AT feniziaclaudio sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris AT moltrasiochiara sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris AT ottobriniluisa sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris AT utyroolga sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris AT genovesegiovanni sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris AT vanetticlaudia sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris AT trabattonidaria sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris AT marzanoangelov sarscov2vaccinationeffectivenessinrituximabtreatedpatientsaffectedbypemphigusvulgaris |